Загрузка...
Estrogen receptor mutations and their role in breast cancer progression
Endocrine therapy is the mainstay of treatment in estrogen receptor-positive breast cancers and significantly reduces disease recurrence and breast cancer-related mortality. However, acquired resistance to therapy has been noted in nearly one-third of women treated with tamoxifen and other endocrine...
Сохранить в:
| Опубликовано в: : | Breast Cancer Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4429420/ https://ncbi.nlm.nih.gov/pubmed/25928204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0494-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|